Page last updated: 2024-08-25

rosiglitazone and Orphan Diseases

rosiglitazone has been researched along with Orphan Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hernandez, AV; Ioannidis, JP; Kattan, MW; Walker, E1

Reviews

1 review(s) available for rosiglitazone and Orphan Diseases

ArticleYear
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.
    American heart journal, 2008, Volume: 156, Issue:1

    Topics: Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypoglycemic Agents; Incidence; Male; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Rare Diseases; Reproducibility of Results; Risk Assessment; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones

2008